Division of Clinical Research
Research Mission |
Organization |
Research Projects
Faculty |
Advisory Committee
Mission
The Division of Clinical Research was established under the leadership of the founding director, Dr. Monto Ho, MD in July 1997. The mission of the Division is to conduct researches on important infectious diseases in Taiwan. Through the information obtained from researches, advocacy is proposed to implement as national policy. Besides the basic and clinical researches, public services are conducted to facilitate the successful implementation of policy. Training programs for the physicians, laboratory technicians, and nurses are also emphasized for successfully achieving these goals. Since infectious disease is a global problem, international collaboration and cooperation are part of the division's endeavors.
The mission of the Division and Specific Aims are:
- To conduct surveillance of antibiotic resistance in several important pathogenic bacteria in Taiwan.
- To identify major causative agents of community acquired pneumonia
- To conduct study of some important infectious diseases to elucidate the epidemiology of these etiological agents and to study the mechanism of development of antimicrobial resistance.
- To survey the yeast infections in Taiwan and to elucidate the molecular mechanism of drug resistance and virulence factors of Candida albicans.
- To conduct the epidemiological studies of viral infection in Taiwan.
- To study the pathogenesis and virulence factors of clinically important viruses in Taiwan.
- To establish animal models to study the pathogenesis and preclinical trial for infectious diseases, especially virus-associated hemophagocytic syndrome and HBV related hepatocellular carcinoma.
- To provide advocacy to government for national policy based on research conclusion.
Organization
Research Projects
- Hepatitis B virus (HBV): Investigating the molecular signaling of HBV pre-S2 mutant-related hepatocarcinogenesis, by Dr. Ih-Jen Su
- Study on antibiotic resistance and epidemiology of clinically important bacteria, by Dr. Leung-Kei Siu
- Epidemiology and Pathogenesis in Medical Mycology, by Dr. Hsiu-Jung Lo
- Surveillance of Antimicrobial Resistance, by Dr. Tsai-Ling Yang Lauderdale
- Epidemiology study of Mycobacterium tuberculosis infection in Taiwan, by Dr. Horng-Yunn Dou
- Pathogenesis and drug resistance in Staphylococcus aureus, by Dr. Feng-Jui Chen
- Contribution of Epstein-Barr Virus(EBV) Reactivation to Inflammatory Events of the Associated Cancers, by Dr. Yao Chang
- Molecular Pathways of Human Oncogenic Herpesviruses, by Dr. Su-Fang Lin
- Clinical and Microbiological Comparison of Different Categories of Staphylococcus aureus Infection in Children, by Dr. Chia-Yu Chi
Advisory Committee
- Cheng T. Cho, M.D. (Chairman)
Professor of Pediatrics
Department of Pediatrics 3045 Wescoe School of Medicine
The University of Kansas Medical Center
3901 Rainbow Blvd. Kansas City, KS 66160 -7330, USA - Mong-Ling Chu, M.D.
Center for Drug Evaluation
1F, No.15-1, Sec. 1, Hangjou South Road, Taipei, Taiwan 100, ROC - Michael M. C. Lai, M.D., Ph.D.
President, National Cheng Kung University
No.1 University Road, Tainan City 701, Taiwan, ROC - Alan Rickinson, Ph.D.
Professor of Cancer Studies
University of Birmingham
Edgbaston Birmingham B152TT UK - Joseph Jao Yiu Sung, M.D., Ph.D.
Professor of Medicine
Associate Dean (General Affairs)
Chairman, Department of Medicine & Therapeutics
Director, Center for Emerging Infectious Diseases
Faculty of Medicine
The Chinese University of Hong Kong - Henrik Caspar Wegener, M.Sc., Ph.D.
Head, Department of Epidemiology and Risk Assessment,
Danish Institute for Food and Veterinary Research, Denmark
Mørkhøj, Bygade 19, DK-2860 Søborg, Denmark